Literature DB >> 25344465

How physician obesity medicine specialists treated obesity before 2012 new drug approvals.

Stacy L Schmidt1, David Bryman, Frank L Greenway, Ed J Hendricks.   

Abstract

BACKGROUND: A survey of obesity medicine specialists was conducted before the approval of new obesity medications in 2012.
METHODS: An Internet survey was sent to obesity medicine specialists inquiring about their practice and prescribing habits.
RESULTS: Twenty-five percent of 1992 obesity medicine specialists responded. They used stimulant obesity medication for longer and at higher doses than recommended in the package insert. Medications for other indications were used off-label alone and in combination for obesity treatment. Only 15 % saw surgical patients.
CONCLUSIONS: The survey is a baseline for when more obesity medications exist in 5 years. We hope discovering a lack of collaboration between obesity medical specialists and obesity surgeons will stimulate more team work that will benefit obese patients contemplating or undergoing obesity surgery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25344465     DOI: 10.1007/s11695-014-1466-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  17 in total

Review 1.  A proposed clinical staging system for obesity.

Authors:  A M Sharma; R F Kushner
Journal:  Int J Obes (Lond)       Date:  2009-02-03       Impact factor: 5.095

2.  Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.

Authors:  Jonathan R Stevens; Timothy E Wilens; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-28

Review 3.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

4.  Health implications of obesity. National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

5.  Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial.

Authors:  John B Dixon; Linda M Schachter; Paul E O'Brien; Kay Jones; Mariee Grima; Gavin Lambert; Wendy Brown; Michael Bailey; Matthew T Naughton
Journal:  JAMA       Date:  2012-09-19       Impact factor: 56.272

6.  The long-term management of obesity with continuing pharmacotherapy.

Authors:  Arthur Frank
Journal:  Obes Res       Date:  2004-11

7.  Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.

Authors:  Ed J Hendricks; Frank L Greenway; Eric C Westman; Alok K Gupta
Journal:  Obesity (Silver Spring)       Date:  2011-04-28       Impact factor: 5.002

8.  Rational design of a combination medication for the treatment of obesity.

Authors:  Frank L Greenway; M J Whitehouse; Maria Guttadauria; James W Anderson; Richard L Atkinson; Ken Fujioka; Kishore M Gadde; Alok K Gupta; Patrick O'Neil; Donald Schumacher; Diane Smith; Eduardo Dunayevich; Gary D Tollefson; Eckard Weber; Michael A Cowley
Journal:  Obesity (Silver Spring)       Date:  2008-11-06       Impact factor: 5.002

9.  Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.

Authors:  A Astrup; R Carraro; N Finer; A Harper; M Kunesova; M E J Lean; L Niskanen; M F Rasmussen; A Rissanen; S Rössner; M J Savolainen; L Van Gaal
Journal:  Int J Obes (Lond)       Date:  2011-08-16       Impact factor: 5.095

10.  The fate of taspoglutide, a weekly GLP-1 receptor agonist, versus twice-daily exenatide for type 2 diabetes: the T-emerge 2 trial.

Authors:  Julio Rosenstock; Bogdan Balas; Bernard Charbonnel; Geremia B Bolli; Mark Boldrin; Robert Ratner; Raffaella Balena
Journal:  Diabetes Care       Date:  2012-11-08       Impact factor: 19.112

View more
  2 in total

1.  Knowledge, attitudes and management skills of medical practitioners regarding weight management.

Authors:  Vangile B Mkhatshwa; Gboyega A Ogunbanjo; Langalibalele H Mabuza
Journal:  Afr J Prim Health Care Fam Med       Date:  2016-11-29

Review 2.  Off-label drugs for weight management.

Authors:  Ed J Hendricks
Journal:  Diabetes Metab Syndr Obes       Date:  2017-06-10       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.